Shigeki Higashiyama

Shigeki Higashiyama

Auto-generated profile, based on publicly available information

Shigeki Higashiyama

Department of Biochemistry and Molecular Genetics Ehime University Graduate School of Medicine Ehime Japan

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 February 2008 in Cancer Science
Verified
Journal Article
Closed access
PDF file
SHShigeki Higashiyama
Shigeki Higashiyama
HIHidehiko Iwabuki
Hidehiko Iwabuki
CMChie Morimoto
Chie Morimoto
MHMiki Hieda
Miki Hieda
HIHirofumi Inoue
Hirofumi Inoue
NMNatsuki Matsushita
Natsuki Matsushita

8 December 2004 in Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
Verified
Journal Article
Closed access
SHShigeki Higashiyama
Shigeki Higashiyama
DNDaisuke Nanba
Daisuke Nanba

3 November 2003 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
DNDaisuke Nanba
Daisuke Nanba
AMAkiko Mammoto
Akiko Mammoto
KHKoji Hashimoto
Koji Hashimoto
SHShigeki Higashiyama
Shigeki Higashiyama
Cleavage of membrane-anchored heparin-binding EGF-like growth factor (proHB-EGF) via metalloprotease activation yields amino- and carboxy-terminal regions (HB-EGF and HB-EGF-C, respectively), with HB-EGF widely recognized as a key element of epidermal growth factor receptor transactivation in G protein–coupled receptor signaling. Here, we show a biological role of HB-EGF-C in cells. Subsequent to proteolytic cleavage of proHB-EGF, HB-EGF-C translocated from the plasma membrane into the nucleus. This translocation triggered nuclear export of the transcriptional repressor, promyelocytic leukemia zinc finger (PLZF), which we identify as an HB-EGF-C binding protein. Suppression of cyclin A and delayed entry of S-phase in cells expressing PLZF were reversed by the production of HB-EGF-C. These results indicate that released HB-EGF-C functions as an intracellular signal and coordinates cell cycle progression with HB-EGF.

1 November 2003 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
SMSeiji Mori
Seiji Mori
MTMotonari Tanaka
Motonari Tanaka
DNDaisuke Nanba
Daisuke Nanba
ENEiji Nishiwaki
Eiji Nishiwaki
HIHiroshi Ishiguro
Hiroshi Ishiguro
NMNariaki Matsuura
Nariaki Matsuura
A disintegrin and metalloprotease 12 (ADAM12/meltrin α) is a key enzyme implicated in the ectodomain shedding of membrane-anchored heparin-binding epidermal growth factor (EGF)-like growth factor (proHB-EGF)-dependent epidermal growth factor receptor (EGFR) transactivation. However, the activation mechanisms of ADAM12 are obscure. To determine how ADAM12 is activated, we screened proteins that bind to the cytoplasmic domain of ADAM12 using a yeast two-hybrid system and identified a protein called PACSIN3 that contains a Src homology 3 domain. An analysis of interactions between ADAM12 and PACSIN3 using glutathione S-transferase fusion protein revealed that a proline-rich region (amino acid residues 829-840) of ADAM12 was required to bind PACSIN3. Furthermore, co-immunoprecipitation and co-localization analyses of ADAM12 and PACSIN3 proteins also revealed their interaction in mammalian cells expressing both of them. The overexpression of PACSIN3 in HT1080 cells enhanced 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced proHB-EGF shedding. Furthermore, knockdown of endogenous PACSIN3 by small interfering RNA in HT1080 cells significantly attenuated the shedding of proHB-EGF induced by TPA and angiotensin II. Our data indicate that PACSIN3 has a novel function as an up-regulator in the signaling of proHB-EGF shedding induced by TPA and angiotensin II.

25 February 2008 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
MHMiki Hieda
Miki Hieda
MIMayumi Isokane
Mayumi Isokane
MKMichiko Koizumi
Michiko Koizumi
CHChiduru Higashi
Chiduru Higashi
TTTaro Tachibana
Taro Tachibana
SHShigeki Higashiyama
Shigeki Higashiyama
Heparin-binding EGF-like growth factor (HB-EGF) is synthesized as a type I transmembrane protein (proHB-EGF) and expressed on the cell surface. The ectodomain shedding of proHB-EGF at the extracellular region on the plasma membrane yields a soluble EGF receptor ligand and a transmembrane-cytoplasmic fragment (HB-EGF-CTF). The cytoplasmic domain of proHB-EGF (HB-EGF-cyto) interacts with transcriptional repressors to reverse their repressive activities. However, how HB-EGF-cyto accesses transcriptional repressors is yet unknown. The present study demonstrates that, after exposure to shedding stimuli, both HB-EGF-CTF and unshed proHB-EGF translocate to the nuclear envelope. Immunoelectron microscopy and digitonin-permeabilized cells showed that HB-EGF-cyto signals are at the inner nuclear membrane. A short sequence element within the HB-EGF-cyto allows a transmembrane protein to localize to the nuclear envelope. The dominant-active form of Rab5 and Rab11 suppressed nuclear envelope targeting. Collectively, these data demonstrate that membrane-anchored HB-EGF is targeted to the inner nuclear membrane via a retrograde membrane trafficking pathway.

15 March 2012 in Blood
Verified
Journal Article
Open access
PDF file
HOHidetaka Ohnuki
Hidetaka Ohnuki
HIHirofumi Inoue
Hirofumi Inoue
NTNobuaki Takemori
Nobuaki Takemori
HNHironao Nakayama
Hironao Nakayama
TSTomohisa Sakaue
Tomohisa Sakaue
SHShigeki Higashiyama
Shigeki Higashiyama
Angiogenic homeostasis is maintained by a balance between vascular endothelial growth factor (VEGF) and Notch signaling in endothelial cells (ECs). We screened for molecules that might mediate the coupling of VEGF signal transduction with down-regulation of Notch signaling, and identified B-cell chronic lymphocytic leukemia/lymphoma6-associated zinc finger protein (BAZF). BAZF was induced by VEGF-A in ECs to bind to the Notch signaling factor C-promoter binding factor 1 (CBF1), and to promote the degradation of CBF1 through polyubiquitination in a CBF1-cullin3 (CUL3) E3 ligase complex. BAZF disruption in vivo decreased endothelial tip cell number and filopodia protrusion, and markedly abrogated vascular plexus formation in the mouse retina, overlapping the retinal phenotype seen in response to Notch activation. Further, impaired angiogenesis and capillary remodeling were observed in skin-wounded BAZF−/− mice. We therefore propose that BAZF supports angiogenic sprouting via BAZF-CUL3-based polyubiquitination-dependent degradation of CBF1 to down-regulate Notch signaling.